We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Covidien’s Exit From Renal Denervation Latest Setback for Promising Technology
Covidien’s Exit From Renal Denervation Latest Setback for Promising Technology
Irish devicemaker Covidien said Tuesday it is halting development on the OneShot renal denervation system, marking yet another blow to a technology once seen as the future of hypertension treatment.